12.4 Protein-Energy Malnutrition: Kwashiorkor, Marasmus & Nutritional Deficiencies

Severe Acute Malnutrition (SAM): Diagnostic Criteria & Classification

Protein-Energy Malnutrition (PEM) represents a major cause of child morbidity and mortality across developing nations and vulnerable socioeconomic enclaves in the Caribbean. Severe Acute Malnutrition (SAM) weakens the immune response, destroys epithelial barrier defenses, induces reductive adaptation across all major organ systems, and predisposes infants to fatal septic shock and metabolic collapse.

The WHO Case Definitions for SAM

In children aged 6 to 59 months, Severe Acute Malnutrition is diagnosed if ANY of the following independent criteria are met:

1. Weight-for-Height / Length < -3 Z-scores (standard deviations) below the median of the WHO Child Growth Standards.
2. Mid-Upper Arm Circumference (MUAC) < 115 mm (identified using the red zone of a standard three-colored Shakir strip).
3. Bilateral Nutritional Pitting Edema: Symmetrical pitting edema involving both feet and lower legs. The presence of bilateral nutritional edema automatically categorizes the child as having SAM, regardless of anthropometric Z-scores or MUAC.

Moderate Acute Malnutrition (MAM)

Defined as a weight-for-height between -2 and -3 SD, or a MUAC between 115 and 124 mm (yellow zone on tape), in the absence of bilateral pitting edema. MAM is managed primarily on an outpatient basis with supplementary food rations and nutritional counseling to prevent progression to SAM.

Clinical Syndromes: Kwashiorkor, Marasmus & Marasmic-Kwashiorkor

+-----------------------------------------------------------------------------------------+
|                        PROTEIN-ENERGY MALNUTRITION: THE SPECTRUM                        |
+-----------------------------------------------------------------------------------------+
                                             |
                   +-------------------------+-------------------------+
                   |                                                   |
                   v                                                   v
            [ KWASHIORKOR ]                                      [ MARASMUS ]
     - Severe Dietary Protein Deficiency                  - Severe Total Caloric + Protein Starvation
     - Carbohydrate-Dense Diet (Starch Gruel)             - Exhaustion of Adipose & Skeletal Protein
     - BILATERAL PITTING PEDAL EDEMA                      - NO NUTRITIONAL EDEMA
     - Preserved Subcutaneous Fat                         - Profound Total Fat & Muscle Depletion
     - Enlarged Steatotic Fatty Liver                     - Normal Liver (No Steatosis)
     - "Moon Facies" (Puffy Cheeks)                       - "Old Man" / "Monkey-Like" Wizened Face
     - "Flaky Paint" Dermatosis & Flag Sign Hair          - Loose, Wrinkled Skin ("Baggy Pants")
     - Profound Misery, Apathy, Anorexia                  - Alert, Irritable, Ravenous Hunger
                   |                                                   |
                   +-------------------------+-------------------------+
                                             |
                                             v
                                  [ MARASMIC-KWASHIORKOR ]
                        - Combined Severe Features of Both Entities
                        - Profound Muscle & Fat Wasting + Bilateral Edema
                        - Carries the Highest Case-Fatality Rate

1. Kwashiorkor (Edematous Malnutrition)

• Etiology & Meaning: Derived from the Ga language of Ghana, translating to "the sickness the older child gets when the next baby is born". It typically manifests when a toddler is abruptly weaned from protein-rich breast milk onto an unfortified, carbohydrate-rich starch gruel (cassava, yam, cornmeal, polished rice).
• Pathophysiology: Severe protein deprivation in the presence of adequate or excess carbohydrate intake leads to profound hypoalbuminemia (< 20 to 25 g/L), lowering plasma oncotic pressure and causing fluid transudation into interstitial spaces (bilateral pitting edema). In addition, chronic oxidant stress and peroxisomal impairment block hepatic apolipoprotein B-100 synthesis; triglycerides synthesized in the liver cannot be packaged into Very Low-Density Lipoproteins (VLDL) for export, resulting in massive intrahepatic lipid accumulation and a soft, non-tender, enlarged fatty liver (hepatic steatosis).
• Clinical Manifestations:
  • Nutritional Edema: Hallmark sign. Begins symmetrically in the dorsum of the feet and pretibial regions (+), extending to the hands, periorbital tissues, and lower legs (++), and progressing to generalized anasarca with ascites (+++).
  • Subcutaneous Adipose Tissue: Relatively preserved beneath the edema.
  • Dermatosis: Pathognomonic "flaky paint" or "enamel paint" dermatosis. Dark, hyperpigmented, hyperkeratotic patches form over friction and pressure areas (buttocks, thighs, perineum), which peel and desquamate to reveal raw, pale, weeping hypopigmented erosions resembling second-degree burns.
  • Hair Changes: The "flag sign" (signe de la bandera), characterized by alternating horizontal bands of normal dark hair and pale, hypopigmented, reddish-yellow hair corresponding to fluctuating periods of protein adequacy and deprivation. Hair becomes dry, dull, brittle, straight, and easily plucked.
  • Facies & Behavior: Rounded, swollen "moon facies"; profound lethargy, apathy, and miserable irritability when touched; severe anorexia.

2. Marasmus (Non-Edematous Severe Wasting)

• Etiology & Pathophysiology: Derived from the Greek marasmos ("wasting away"). Represents a balanced, severe chronic deficiency of both total energy (calories) and protein—a state of progressive starvation. The body mobilizes all available subcutaneous adipose tissue via lipolysis and catabolizes skeletal muscle via proteolysis to fuel essential cerebral and cardiac metabolism.
• Clinical Manifestations:
  • Profound Wasting: Severe generalized loss of muscle mass (temporalis, pectoralis, deltoids, gluteals, quadriceps) and complete depletion of subcutaneous fat stores. Prominent ribs give a "barrel-chested" skeleton-like appearance.
  • Facies: Aged, shrunken, wrinkled "wizened old man" or "little monkey" facial appearance resulting from the complete loss of buccal fat pads (Bichat's fat pads).
  • Skin & Gluteal Fold: Dry, thin, wrinkled skin that hangs in redundant loose folds around the thighs and gluteal region, classically resembling "baggy pants" or loose trousers.
  • Edema & Liver: Complete absence of nutritional edema. The liver is normal in size without fatty infiltration because lipid synthesis is halted.
  • Behavior: Alert, anxious, irritable, with a ravenous, voracious appetite (readily consumes feeds, contrasting with the severe anorexia of kwashiorkor).

3. Marasmic-Kwashiorkor

A severe mixed entity characterized by features of both conditions: profound muscle wasting and absent subcutaneous fat alongside bilateral pitting pedal edema, often accompanied by dermatosis and enlarged liver. It carries the highest inpatient mortality rate among all malnourished children.

The WHO 10-Step Inpatient Management Protocol

Critically ill children with SAM suffer from reductive adaptation—every organ system has slowed down to survive on minimal resources (cardiac output is reduced, renal filtration is decreased, intestinal brush-border disaccharidases are depleted, and immune competence is abolished). Uncontrolled rapid fluid administration and aggressive initial feeding can cause dangerous overload or metabolic deterioration; resuscitation must be monitored and tailored to the underlying illness. The WHO 10-step inpatient protocol applies to complicated SAM: danger signs, acute medical problems, severe oedema(+++) or failed appetite test. Uncomplicated SAM with good appetite can be treated through an outpatient therapeutic programme. Stabilization and rehabilitation timing follows clinical recovery rather than a fixed calendar.

Critical Management Pitfalls in SAM

1. Fluid Resuscitation Hazards in Dehydration & Shock

• The Clinical Trap: Traditional physical signs of dehydration (sunken eyes, dry mucous membranes, delayed skin pinch) are inherently unreliable. In marasmus, loss of subcutaneous fat causes chronic skin tenting; in kwashiorkor, tissue edema masks intravascular volume depletion.
• Oral Rehydration: For SAM with dehydration but no shock, use supervised ReSoMal (Na 45 mmol/L, K 40 mmol/L):5 mL/kg every 30 minutes for 2 hours, then 5–10 mL/kg/hour, reassessing frequently and alternating with F-75 feeds. Low-osmolarity WHO-ORS may be used if ReSoMal is unavailable. Suspected cholera or profuse watery diarrhoea requires standard low-osmolarity ORS, not ReSoMal, to replace larger sodium losses.
• IV Fluid Hazards: Avoid unmonitored rapid boluses in SAM. Fluid overload can cause pulmonary oedema, but circulatory shock still requires prompt, carefully monitored resuscitation. Assess the cause, haemoglobin, glucose, perfusion and signs of overload; reassess throughout treatment, not only after an hour.
• Shock Management: Cold extremities, weak fast pulse and capillary refill>3 seconds indicate shock; assess consciousness and the cause urgently. A cautious SAM regimen is 10–15 mL/kg over 1 hour of balanced isotonic crystalloid, with glucose supplied as needed. Reassess every 5–10 minutes and stop/reduce fluids for overload. Persistent shock requires urgent senior/critical-care reassessment and cause-directed treatment, including vasoactive support when indicated. In non-haemorrhagic shock with SAM and Hb<=6 g/dL, or severe pallor when Hb is unavailable and initial treatment fails, WHO recommends 5–10 mL/kg packed red cells (preferred) or 10 mL/kg whole blood over at least 3 hours. Move to oral/NG fluids when shock has resolved and enteral treatment is safe.

2. The Strict Ban on Iron in Phase 1 (Stabilization)

Iron supplementation is strictly contraindicated during Phase 1 Stabilization. In children with SAM, circulating transferrin levels are profoundly depressed due to defective hepatic protein synthesis. Administering exogenous iron results in high concentrations of unbound, free ionic iron in serum. Free iron acts as an essential growth nutrient for pathogenic bacteria (Klebsiella, E. coli, Salmonella), transforming indolent bacteremia into fulminant, fatal septic shock. Furthermore, free iron catalyses the Fenton reaction, generating toxic hydroxyl free radicals that induce systemic membrane lipid peroxidation. Do not give iron during stabilization. During rehabilitation, add elemental iron 3 mg/kg/day after 2 days on F-100 once appetite and weight gain return. Do not add iron to RUTF, which already contains it.

3. Refeeding Syndrome: Mechanism & Prevention

Refeeding syndrome is a life-threatening metabolic complication that occurs when aggressive carbohydrate feeding is prematurely introduced to a severely starved child. In prolonged starvation, the body shifts from carbohydrate metabolism to fat oxidation and ketone body utilization, depleting intracellular phosphate stores.

• Mechanism: When carbohydrates are ingested, blood glucose rises, stimulating massive endogenous insulin release. Insulin stimulates cellular glucose uptake and activates the sodium-potassium ATPase pump, driving phosphate, potassium, and magnesium from the extracellular space into the intracellular compartment to synthesize ATP and 2,3-diphosphoglycerate (2,3-DPG).
• Consequences: Precipitous, severe hypophosphatemia (< 0.5 mmol/L), hypokalemia, and hypomagnesemia. Severe hypophosphatemia prevents cellular ATP synthesis, causing diaphragmatic and respiratory muscle weakness, acute respiratory arrest, myocardial dysfunction, refractory ventricular arrhythmias, rhabdomyolysis, seizures, and sudden cardiac death.
• Prevention: Adhere strictly to F-75 formula during Phase 1 (low energy density, protein and sodium:75 kcal/100 mL,0.9 g protein/100 mL), with electrolyte/thiamine provision and monitoring; it is not a low-carbohydrate feed. Caloric intake must not exceed 100 kcal/kg/day initially. Transition to high-calorie F-100 or RUTF must be gradual and executed only after metabolic stabilization.

Specific Micronutrient Deficiencies: Recognition, Pathology & Management

1. Vitamin A Deficiency (VAD) & Xerophthalmia

Vitamin A (retinol) is an essential fat-soluble vitamin required for visual phototransduction (rhodopsin in retinal rods) and the maintenance of differentiated mucus-secreting epithelial surfaces (cornea, conjunctiva, respiratory, and intestinal tract).

• WHO Clinical Classification of Xerophthalmia:
  • XN - Night Blindness (Nyctalopia): Earliest functional ocular sign; caused by delayed rhodopsin regeneration in rods. The child bumps into objects at dusk.
  • X1A - Conjunctival Xerosis: Dry, lustreless, thickened, wrinkled bulbar conjunctiva that loses its normal wettability.
  • X1B - Bitot's Spots: Pathognomonic lesion. Elevated, triangular, foamy, silvery-white or pearly patches composed of keratinized epithelial debris located on the bulbar conjunctiva, typically temporal to the limbus.
  • X2 - Corneal Xerosis: Hazy, dull, dry cornea with punctate erosions.
  • X3A / X3B - Corneal Ulceration & Keratomalacia: Liquefactive necrosis of the corneal stroma. X3A involves < 1/3 of corneal area; X3B involves > 1/3 of corneal surface, leading to corneal perforation, iris prolapse, endophthalmitis, and permanent bilateral blindness.
  • XS - Corneal Scarring: Dense, white, opacified scars resulting from healed ulceration.
• Treatment Protocol: Oral high-dose Vitamin A (retinyl palmitate) administered on Day 1, Day 2, and Day 14 (age < 6 months: 50,000 IU; 6 to 12 months: 100,000 IU; > 12 months: 200,000 IU per dose).

2. Vitamin D Deficiency Rickets

Rickets is a disorder of defective mineralization of the organic osteoid matrix at the epiphyseal growth plates of growing bones prior to physeal fusion (contrasting with osteomalacia, which occurs in mature remodeled bone after physeal closure).

• Risk Factors: Inadequate skin synthesis of cholecalciferol from 7-dehydrocholesterol due to lack of sunlight exposure; dark skin pigmentation (melanin absorbs UVB radiation); exclusive breastfeeding beyond 6 months without oral vitamin D supplementation (human breast milk contains negligible vitamin D, ~25 to 50 IU/L); maternal vitamin D deficiency; chronic malabsorption.
• Pathophysiology: Low circulating 25-hydroxyvitamin D [25(OH)D] reduces intestinal calcium and phosphorus absorption. Transient hypocalcemia stimulates parathyroid hormone (PTH) hypersecretion (secondary hyperparathyroidism). PTH mobilizes calcium from bone and stimulates renal 1-alpha-hydroxylase to produce calcitriol (1,25(OH)2D), maintaining normal or near-normal serum calcium at the expense of severe renal phosphate wasting (hypophosphatemia). Without adequate calcium-phosphate solubility product, chondrocyte apoptosis is delayed and mineralized osteoid cannot form, leading to excessive, disordered accumulation of unmineralized, compliant osteoid tissue at the metaphysis.
• Clinical Signs:
  • Cranial: Craniotabes (soft, ping-pong ball-like thinning of parietal and occipital bones under finger pressure; earliest sign, detectable < 3 months), delayed closure of the anterior fontanelle (> 18 to 24 months), frontal bossing (prominent forehead), caput quadratum.
  • Thoracic: Rachitic rosary (prominent, non-tender, symmetrical beading at the costochondral junctions, resembling a string of beads); Harrison's groove / sulcus (horizontal groove along the lower border of the thorax corresponding to the diaphragmatic traction on softened, compliant ribs); pectus carinatum (pigeon chest).
  • Extremities: Metaphyseal enlargement causing painless symmetrical widening of the wrists and ankles; once weight-bearing begins, softened long bones bow under gravity, producing bow legs (genu varum) or knock-knees (genu valgum); coxavara.
  • Neuromuscular: Hypocalcemic tetany, carpopedal spasm, laryngospasm (stridor), generalized seizures, muscular hypotonia, and delayed motor milestones.
• Radiological Hallmarks (Anterior-Posterior Wrist & Knee X-ray):
  • Cupping: Concave, cup-like depression of the metaphyseal margin.
  • Splaying: Metaphyseal flaring and lateral widening.
  • Fraying / Brushing: Irregular, ragged, brush-like metaphyseal border.
  • Widened Physis: Increased distance between the metaphysis and the ossification center (radiolucent non-mineralized zone).
  • Generalized osteopenia and cortical thinning.
• Biochemical Profile:
  • Serum Calcium: Normal or mildly decreased.
  • Serum Phosphate: Low (due to PTH-mediated phosphaturia).
  • Alkaline Phosphatase (ALP): Markedly elevated (hallmark of compensatory osteoblastic hyperactivity; best marker to monitor therapeutic healing).
  • Parathyroid Hormone (PTH): Elevated.
  • Serum 25-hydroxyvitamin D [25(OH)D]: Low (< 30 nmol/L or < 12 ng/mL).
• Treatment: Manage nutritional rickets with specialist guidance. Give oral vitamin D for at least 3 months: commonly 2,000 IU/day in infants,3,000–6,000 IU/day at 1–12 years, and 6,000 IU/day in older children/adolescents. Ensure at least 500 mg/day elemental calcium through diet/supplementation throughout treatment. Treat symptomatic hypocalcaemia urgently and monitor calcium, phosphate, ALP and 25(OH)D. Stoss regimens require age-specific specialist prescribing and are not a routine option for young infants. After healing, maintain vitamin D 400 IU/day in infancy and 600 IU/day thereafter with adequate calcium.

3. Iron Deficiency Anemia (IDA)

Iron deficiency is the most prevalent nutritional disorder worldwide and across the Caribbean. In infants and young children, iron is essential not only for hemoglobin synthesis in erythrocytes but also as an enzymatic cofactor for neuronal myelination, neurotransmitter synthesis (dopamine, serotonin), and hippocampal dendritic growth.

• Etiology & Risk Factors:
  • Prematurity and low birth weight: Fetal iron stores are accumulated primarily during the third trimester; preterm infants exhaust stores by 2 months of age.
  • Prolonged exclusive breastfeeding beyond 6 months without iron-rich complementary foods.
  • Early introduction of unmodified whole cow's milk before 12 months of age: Cow's milk has low iron bioavailability, inhibits non-heme iron absorption due to high calcium and casein content, and provokes microscopic enteropathy with chronic occult intestinal blood loss.
  • Intestinal helminth infections (hookworm: Necator americanus, Ancylostoma duodenale), common in rural agricultural Caribbean communities.
• Clinical Manifestations: Conjunctival, mucosal, and palmar crease pallor (palmar pallor correlates with Hb < 8 g/dL), irritability, fatigue, tachycardia, systolic flow murmurs, pica (compulsive consumption of non-nutritive substances: soil/geophagia, ice/pagophagia, chalk), atrophic glossitis, angular cheilitis, and koilonychia (spoon-shaped concave nails). Long-standing IDA causes permanent neurodevelopmental and cognitive deficits.
• Laboratory Profile:
  • Complete Blood Count: Microcytic hypochromic anemia (low Hb, low MCV < 70 to 75 fL, low MCH, low MCHC).
  • Red Cell Distribution Width (RDW): Markedly elevated (RDW > 15%), reflecting significant variation in red cell size (anisocytosis). An elevated RDW cleanly differentiates IDA from Beta-Thalassemia Trait, which presents with uniform microcytosis, a normal RDW (< 14%), a Mentzer Index (MCV / RBC count) < 13, and normal or elevated ferritin.
  • Serum Ferritin: Low (< 12 to 15 mcg/L). Ferritin is the single most sensitive and specific marker of depleted bone marrow iron stores. Caveat: Ferritin is an acute-phase reactant; in the presence of concurrent infection or inflammation, ferritin may be falsely normal or elevated.
  • Serum Iron: Low; Total Iron Binding Capacity (TIBC): High; Transferrin Saturation: Low (< 16%).
• Treatment Protocol:
  • Oral Ferrous Sulfate at 3 to 6 mg of elemental iron/kg/day divided into 1 to 2 daily doses.
  • Administration: Administer between meals or with citrus juice (Vitamin C reduces ferric iron to ferrous iron, enhancing absorption). Do not administer with milk, tea, or antacids.
  • Therapeutic Response Timeline: Reticulocytosis peaks at 5 to 7 days; hemoglobin concentration rises by 1 to 2 g/dL within 2 to 4 weeks.
  • Duration: Oral iron therapy must be continued for 2 to 3 months AFTER the hemoglobin has normalized to replenish depleted bone marrow iron stores.